Pavel is a physician-scientist and former Head of Translational Medicine at Roche/Genentech, with broad experience from more than 50 programs in early- and late-stage clinical drug development. He has in-depth knowledge of the experimental and clinical challenges of drug development with real-life experience of successfully translating scientific findings into medicines and innovative treatment modalities. Pavel also has a distinguished academic, clinical and scientific career at world-leading medical institutions with authorship of 115 highly-cited publications and patents within tumour immunology. He holds a PhD in Immunology, and is an M.D. certified in Internal Medicine, Medical Haematology and Medical Oncology.
“It’s truly rewarding for me to be part of a team that aims for ambitious goals never previously explored.”